CKD-330 Phase 3 Trial in Amlodipine Non-responder

Phase 3 Completed 160 enrolled Chong Kun Dang Pharmaceutical

RandomizedParallel-groupDouble-blindTreatment

Summary

Trial to Evaluate the Efficacy and Safety of a CKD-330 versus Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by Amlodipine Monotherapy

Timeline

Start: 2016-01
Primary completion: 2016-08
Completion: 2016-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Amlodipine	Other / unclassified	5 mg	Oral
Subject	CKD-330	Unknown	—	Oral

CKD-330 Phase 3 Trial in Amlodipine Non-responder

Summary

Timeline

Drugs

Indications